Surfactant replacement therapy in experimental and clinical studies

Applied Cardiopulmonary Pathophysiology

Volumn 7, Issue 4, 1998, Pages 237-250

  Verbrugge, Serge J C ^a   Lachmann, Burkhard ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Animal; ARDS; Clinical; Surfactant

Indexed keywords

AMBROXOL; HYDROCHLORIC ACID; LUNG SURFACTANT; MONOCLONAL ANTIBODY;

ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BIOCHEMISTRY; BIOPHYSICS; CARDIOPULMONARY BYPASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CYSTIC FIBROSIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG INFECTION; LUNG INSUFFICIENCY; LUNG LAVAGE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NONHUMAN; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0032462693     PISSN: 09205268     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (147)

1. Segerer H, Obladen M, Surfactant substitution treatment of neonatal respiratory distress syndrome. Pediatric Rev Commun 1990; 5: 67-82
2. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993;328:861-868
3. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147: 218-233
4. Holm BA, Matalon S, Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome. Anesth Analg 1989; 69: 805-818
5. Brogden KA. Changes in pulmonary surfactant during bacterial pneumonia. Antonievan Leeuwenhoek 1991; 59: 215-223
6. do Campo JL, Bertranou EG, Casellas A, Bonatto P, Battellini R. Pulmonary surfactant post cardiac surgery with cardiopulmonary bypass. Am Rev Respir Dis 1990; 141(Suppl): A512
7. Berggren P, Lachmann B, Curstedt T, Grossmann G, Robertson B, Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Acta Anaesthesiol Scand 1986; 30: 321-328
8. Gommers D, Vilstrup C, Bos JAH, Larsson A, Werner O, Hannappel E, Lachmann B. Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Crit Care Med 1993; 21: 567-574
9. Berry D, Ikegami M, Jobe A. Respiratory distress and surfactant inhibition following vagotomy in rabbits. J Appl Physiol 1986; 61: 1741-1748
10. Loewen GM, Holm BA, Milanowski L, Wild LM, Notter RH, Matalon S. Alveolar hyperoxic injury in rabbits receiving exogenous surfactant, J Appl Physiol 1989; 66: 1087-1092
11. Matalon S, Holm BA, Notter RH. Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant. J Appl Physiol 1987; 62: 756-761
12. Lachmann B, Saugstad OD, Erdmann W. Effects of surfactant replacement on respiratory failure induced by free oxygen radicals. First Vienna Shock Forum. Part B: Monitoring and Treatment of Shock: 1987, pp 305-313
13. Kobayashi T, Ganzuka M, Tanigushi J, Nitta K, Murakami S. Lung lavage and surfactant replacement for hydrochloric acid aspiration in rabbits. Acta Anaesthesiol Scand 1990; 34: 216-221
14. Eijking FP, Gommers D, So KL, de Maat MPM, Mouton JW, Lachmann B. Prevention of respiratory failure after hydrochloric acid aspiration by intratracheal surfactant instillation in rats. Anesth Analg 1993; 76: 472-477
15. Fijking FP, Gommers D, So KL, Vergeer M, Lachmann B. Surfactant treatment of respiratory failure induced by hydrochloric acid aspiration in rats. Anesthesiology 1993; 78: 1145-1151
16. So KL, van Genderen PJJ, Gommers D, Lachmann B. Different surfactant treatment strategies for respiratory failure induced by tracheally instilled pooled human plasma in rats. Am Rev Respir Dis 1993: 147 [Suppl]: A351
17. Harris JD, Jackson F, Moxley MA, Longmore WJ. Effect of exogenous surfactant instillation on experimental acute lung injury. J Appl Physiol 1989; 66: 1846-1851
18. So KL, de Buijzer E, Gommers D, Kaisers U, van Genderen PJJ, Lachmann B. Surfactant therapy restores gas exchange in lung injury due to paraquat intoxication in rats. Eur Respir J (In press).
19. Robertson B, Lachmann B. Experimental evaluation of surfactants for replacement therapy. Exp Lung Research 1988: 14: 279-310
20. Lachmann B, Grossmann G, Freyse J, Robertson B. Lung-thorax compliance in the artificially ventilated premature rabbit neonate in relation to variations in mspiratory:expiratory ratio. Pediatr Res 1981: 15: 833-838.
21. Lachmann B, Berggren P, Curstedt T, Grossmann G, Robertson B. Combined effects of surfactant substitution and prolongation of inspiration phase in artificially ventilated premature newborn rabbits. Pediatr Res 1982; 16: 921-927.
22. Nilsson R. The artificially ventilated preterm rabbit neonate as experimental model of hyaline membrane disease. Acta Anaethesiol Scand 1982; 26: 89-103.
23. Ikegami M, Adams FH. Towers B, Osher AB. The quantity of natural surfactant necessary to prevent the respiratory distress syndrome in premature lambs. Pediatr Res 1980; 14: 1082-1085
24. Ikegami M, Jobe A, Jacobs H, Jones S. Sequential treatments of premature lambs with an artieificial surfactant and natural surfactant. J Clin Invest 1981; 68: 491-496.
25. Crittenden DJ. Beekman DL. Traumatic head injury and pulmonary damage. J Trauma 1982: 22; 766-769.
26. Goldenberg VE. Buckingham S, Sommers SC. Pulmonary alveolar lesions in vagotomized rats. Lab Invest 1967; 16: 693-705.
27. Berry D, Ikegami M, Jobe A. Respiratory distress and surfactant inhibition following vagotomy in rabbits. J Appl Physiol 1986; 61: 1741-1748.
28. Klein J. Normobaric pulmonary oxygen toxicity. Anesth Analg 1990: 70: 195-207.
29. Cochrane CG, Spragg R, Revak SD. Pathogenesis of the adult respiratory distress syndrome: evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest 1983: 71: 754-761.
30. Ennema JJ, Kobayashi T, Robertson B, Curstedt T. Inactivation of exogenous surfactant in experimental respiratory failure induced by hyperoxia. Acta Anaesthesiol Scand 1988: 32: 665-671.
31. Saugstad OD, Hallman M, Abraham J, Cochrane CG, Epstein B, Gluck L. Hypoxanthine and oxygen induced lung injury: a possible basic mechanism of tissue damage? Pediatr Res 1984; 18: 501-504.
32. Oldham KT, Guice KS, Stetson PS, Wolfe RR. Bacteremia-induced suppresion of alveolar surfactant production. J Surg Res 1989: 47: 397-402.
33. Rinaldo JE, Dauber JH, Christman J, Rogers RM. Neutrophil alveolitis following endotoxemia. Enhancement by previous exposure to hyperoxia. Am Rev Resp Dis 1984; 130: 1065-1071.
34. Mustard RA, Fusher J, Hayman S, Matlow A, Mullen JBM. Odumeru J, Rooni MW, Schouten BD, Swanson HT. Cardiopulmonary responses to Pseudomonas septicemia in swine: An improved model of the adult respiratory distress syndrome. Lab Anim Science 1989; 39: 37-43.
35. Hanly P, Light RB. Lung mechanics, gas exchange, pulmonary perfusion, and hemodynamics in a canine model of acute Pseudomonas pneumonia. Lung 1987; 165: 305-322.
36. Lewis JF, Ikegami K, Jobe AH. Altered surfactant function and metabolism in rabbits with acute lung injury. J Appl Physiol 1990; 69: 2302-2310.
37. Ryan SF, Liau DF, Bell ALL, Hashim SA, Barrett CR. Correlation of lung compliance and quantities of surfactant phospholipids after acute alveolar injury from N-nitroso-N-methylurethane in the dog. Am Rev Resp Dis 1981; 23: 200-204.
38. Hall SB, Notter RH, Smith RJ, Hyde RW. Altered function of pulmonary surfactant in fatty acid lung injury. J Appl Physiol 1990; 69: 1143-1149.
39. Zelter M, Escudier J, Hoeffel JM, Murray JF. Effects of aerolized artificial surfactant on repeated oleic acid injury in sheep. Am Rev Resp Dis 1990; 141: 1014-1019.
40. Manktelow BW. Loss of pulmonary surfactant in paraquat poisoning. Brit J Exp Path 1967; 48: 366-369.
41. Robertson B, Enhorning G, Ivemark B, Malmquist E, Modee J. Experimental respiratory distress induced by paraquat. J Path 1971; 103: 239-244.
42. Henry JN, McArdle AH, Bounous G, Hampson LG, Scott HJ, Gurd FN. The effect of experimental hemorrhagic shock on pulmonary alveolar surfactant. J Trauma 1967: 7: 691-726.
43. Moss GS, Newson B, Das Gupta TK. The normal histochemistry and the effect of hemorrhagic shock on the pulmonary surfactant system. Surg Gynaec Obstet 1975; 40: 53-58.
44. Stephens KE, Ishizaka A, Larrick JW, Raffin TA. Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Resp Dis 1988: 137: 1364-1370.
45. Nieman GF, Goyette D, Paskanik A. Bredenberg C. Surfactant displacement by plasma lavage results in pulmonary edema. Surgery 1990: 107: 677-683.
46. Kaneko T, Sato T, Katsuya H, Miyauchi Y. Surfactant therapy for pulmonary edema due to intratracheally injected bile acid. Crit Care Med 1990; 70: 195-207.
47. Fujiwara T, Adams FH, El-Salawy A, Sipos S. Alveolar and whole lung phospholipids of newborn lambs. Proc Soc Exp Biol Med (N.Y.) 1968; 127: 962-969.
48. Lachmann B, Robertson B, Vogel J. In vivo lung lavage as an experimental model of respiratory distress syndrome. Acta Anaesthesiol Scand 1980; 24: 231-236.
49. Lachmann B, Jonson B. Lindroth M, Roberston B. Modes of artificial ventilation in severe respiratory distress syndrome. Lung function and morphology in rabbits after wash-out of alveolar surfactant. Crit Care Med 1982; 16: 921-927.
50. Huber GL, Edmunds LH, Finley TN. Effects of experimental saline lavage on pulmonary mechanics and morphology. Am Rev Resp Dis 1971; 104: 337-347.
51. Johnson JWC, Permutt S, Sipple JH, Salem ES. Effect of infra-alveolar fluid on pulmonary surface tension properties. J Appl Physiol 1964; 19: 769-777.
52. 99mTc-DTPA: Effects of surfactant depletion by lung lavage. J Appl Physiol 1987; 62: 1611-1614.
53. Kobayashi T, Kataoka H, Ueda T, Murakami S, Takada Y, Kokubo M. Effect of surfactant supplement and end-expiratory pressure in lung -lavaged rabbits. J Appl Physiol 1984; 57: 995-1001.
54. Lachmann B, Fujiwara T, Chida S, Morita T, Konishi M, Nakamura K, Maeta H. Surfactant replacement therapy in the experimental adult respiratory distress syndrome (ARDS). In: Cosmi EV, Scarpelli (eds.) Pulmonary surfactant System. Amsterdam. Elsevier, 1983: 231-235.
55. Gommers D, van 't Veen A, Verbrugge SJC, Lachmann B. Comparison of eight different surfactant preparations on improvement of blood gases in lung-lavaged rats. Applied Cardiopulmonary Pathophysiology 1998; 7: 95-102.
56. 99mTc-DTPA clearance in respiratory failure in rabbits. Brit J Anaesth 1989; 63: 59S-64S.
57. Eijking EP, Strayer DS, van Daal GJ, Tenbrinck R, Merrirt TA, Hannappel E. Lachmann B. In vivo and in vitro inactivation of bovine surfactant by an anti-surfactant monoclonal antibody. Eur Respir J 1991; 4: 1245-1250.
58. Sutnick AI, Soloff LA. Atelectasis with pneumonia. A pathophysiology study. Ann Internal Med 1964; 60: 39-46
59. Somerson NL, Kontras SB, Pollack JD, Weiss HS. Pulmonary compliance: alteration during infection. Science 1971; 171: 66-68
60. Mink SN, Light RB, Wood LDH. Effect of pneumococcal lobar pneumonia on canine lung mechanics. J Appl Physiol 1981; 50: 283-291
61. Baughman RP, Sternberg RI, Hull W, Buchsbaum JA, Whitsett J. Decreased surfactant protein A in patients with bacterial pneumonia. Am Rev Respir Dis 1993; 147: 653-657
62. Stinson SF, Ryan DP, Hertweck MS, Hardy JD, Hwang-Kow SY, Loosli CG. Epithelial and surfactant changes in influenza pulmonary lesions. Arch Pathol Lab Med 1976; 100: 147-153
63. Escamilla R, Prevost MC, Hermant C, Caratero A, Cariven C, Krempf M. Surfactant analysis during pneumocystis carinii pneumonia in HIV-infectcd patients. Chest 1992; 101: 1558-1562
64. Hoffman AGD, Lawrence MG, Ognibene FP, Suffredini AF, Lipschik GY, Kovacs JA, Masur H, Shelhamer JH. Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and pneumocystis carinii pneumonia. Chest 1992; 102: 1730-1736
65. Lachmann B, Eijking EP, So KL, Gommers D. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intens Care Med 1994; 20: 6-11
66. Seeger W, Günther A, Walmrath HD, Grimminger F, Lasch HG. Alveolar surfactant and adult respiratory distress syndrome. Clin Investigator 1993; 71: 177-190
67. Guyton AC, Moffatt DS, Adair TA. Role of alveolar surface tension in transepithelial movement of fluid. In: Robertson B, van Golde LMG, Batenburg JJ (Eds). Pulmonary surfactant. Elsevier, Amsterdam, 1984, pp 171-185
68. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med 1992; 18: 319-321
69. van Daal GJ, Bos JAH, Eijking EP, Gommers D, Hannappel E, Laehmann B. Surfactant replacement therapy improves pulmonary mechanics in end-stage influenza A pneumonia in mice. Am Rev Respir Dis 1992; 145: 859-863
70. van Daal GJ, So KL, Gommers D, Eijking EP, Fiévez RB, Sprenger MJ, Van Dam DW, Lachmann B. Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth Analg 1991; 72: 589-595
71. Eijking EP, Van Daal GJ, Tenbrinck R, Luijendijk A, Sluiters JF, Hannappel E, Lachmann B. Effect of surfactant replacement on pneumocystis carinii pneumonia in rats. Intens Care Med 1991; 17: 475-478
72. Song G-W, Robertson B, Curstedt T, X-Z Gan, Huang W-X. Surfactant treatment in experimental Escherichia coli pneumonia. Acta Anaesthesiol Scand 1996; 40: 1154-1160
73. Awe WD, Fletcher WS, Jacob SW. The pathophysiology of aspiration pneumonitis. Surgery 1966; 60: 232-239
74. Green field LJ, Singleton RP, McCaffree DR, Coalson JJ. Pulmonary effects of experimental graded aspiration of hydrochloric acid. Ann Surg 1969; 170: 74-86
75. Toung TJ, Saharia P, Permutt S, Zuidema GD, Cameron JL. Aspiration pneumonia: beneficial and harmfull effects of positive end-expiratory pressure. Surgery 1977; 82: 279-283
76. Gibbs CP, Modell JH. Management of aspiration pneumonitis. In: Miller RD (ed) Anesthesia. New York. Edinburgh, London, Melbourne: Churchill Livingstone, 1990: 1293-1319
77. Baum KF, Beekman DL. Aspiration pneumonitis and pulmonary phospholipids. J Trauma 1976; 16: 782-787
78. Brown ES. Aspiration and lung surfactant. Anesth Analg 1967; 46: 665-672
79. Lamm WJE, Albert RK. Surfactant replacement improves lung recoil in rabbit lungs after acid aspiration. Am Rev Resp Dis 1990; 142: 1279-1283
80. So KL, Eijking EP, Gommers D, de Buijzer E, Beukenholdt RW, Lachmann B. Different surfactant treatment strategies for respiratory failure induced by hydrochloric acid aspiration in rats. Intens Care Med 1992; 18: Suppl 3: S111
81. Suzuki Y, Robertson R, Fujita Y, Grossman G. Respiratory failure in mice caused by a hybridoma making antibodies to the 15 kDa surfactant apoprotein. Acta Anaesthesiol Scand 1988; 32: 283-289
82. Kobayashi T, Nitta K, Takahashi R, Kurashima K, Robertson B, Suzuki Y. Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B. J Appl Physiol 1991; 71: 530-536
83. Robertson B, Kobayashi T, Ganzuka M, Grossman G, Li WZ, Suzuki Y. Experimental neonatal respiratory failure induced by monoclonal antibody to the hydrophobic surfactant-associated protein SP-B. Pediatr Res 1991; 30: 239-243
84. Lachmann B, Bergmann K-Ch, Winsel K, Eckert H, Wuthe H, Vogel J, Experimentelles Atemnotsyndrom nach Injection von Anti-Lungenserum. II Morphologische, biochemische, physikochemische und immunologische Befunde. Pädiatr Grenzgeb 1973; 12: 403-414
85. Lachmann B, Bergmann K-Ch, Winsel K, Müller E, Petro W, Schäfer C, Vogel J. Experimetelles Atemnotsyndrom nach Injektion von Anti-Lungserum. III Atemmechanische, blutgasanalystische, physikochemische und biochemische Befunde in chronische Versuch; Therapieversuche. Pädiatr Grenzgeb 1975; 14: 211-233
86. Lachmann B, Bergmann K-Ch, Vogel J. Experimentelles Atemnotsyndrom nach Injektion von Anti-Lungenserum. I Atemmechanische, roentgenologische und blutanalytische Befunde. Pädiatr Grenzgeb 1973; 12: 347-364
87. Lachmann B, Hallmann M, Bergmann KC. Respiratory failure following anti-lung serum: study on mechanisms associated with surfactant system damage. Exp Lung Res 1987; 12: 163-180
88. McFadden ERJr. Gilbert 1A. Asthma. N Engl J Med 1992;327: 1928-1937
89. Macklem PT. Proctor DF, Hogg JC, The stability of peripheral airways. Resp Physiol 1970; 8: 191-203
90. Hohfield J, Fabel H, Hamm H. The role of pulmonary surfactant in obstructive airways disease. Fur Respir J 1997; 10: 482-491
91. Smith BT. Pulmonary surfactant during fetal development and neonatal adaptation; hormonal control. In; Robertson B, van Golde LMG, Batenburg JJ (Eds). Pulmonary surfactant. Elsevicr, Amsterdam, 1984, pp 357-381
92. Robertson B. Corticosteriods and surfactant for prevention of neonatal RDS. Ann Med 1993; 25 :285-288
93. Liu M, Wang L, Enhorning G. Surfactant dysfunction develops when the immunized guinea-pig is challenged with ovalbumin aerosol. Clin Exp Allergy 1995; 25: 1053-1060
94. Liu M, Wang L, Holm BA, Enhorning G. Dysfunction of guinea-pig pulmonary surfactant and type II pneumocytes after repetitive challenge with aerosolized ovalbumin. Clin Exp Allergy 1997; 27: 802-807
95. Lachmann B, Becher G. Protective effect of lung surfactant on allergic bronchial constriction in guinea pigs. Am Rev Resp Dis 1986; 133: A118
96. Liu M, Wang L, Li E, Enhorning G. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea pigs. Clin Exp Allergy 1996; 26: 270-275
97. Fegiz G. Prevention by ambroxol of broncho-pulmonary complications after abdominal surgery : double-blind Italian multicenter study versus placebo. Lung 1991; 169: 69-76
98. Ashbaugh DG, Bingelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2: 319-323
99. Veldhuizen RAW, McCaig LA, Akino T, Lewis JF. Pulmonary surfactant sufractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152: 1867-1871
100. Lachmann B, Danzmann E. Adult respiratory distress syndrome. In Roberlson B. van Golde LMG, Batenburg JJ (eds). Pulmonary surfactant. Elsevier, Amsterdam. 1984, pp 505-548
101. Krafft P, Fridrich P, Pernerstorfer T, Fitzgerald RD, Koc D. Schneider B, Hammerle AF. Steltzer H. The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations. Intens Care Med 1996; 22: 519-529
102. Doyle RE, Szaflarski N, Modin GW, Wiener-Kronish JP, Matlay MA. Identification of patients with acute lung injury: predictors of mortality. Am J Respir Crit Care Med 1995: 152: 1818-1824
103. Royall JA, Eevin DL. Adult respiratory distress syndrome in pediatric patients. I: Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. J Pediatr 1988; 112: 169-180
104. van Golde LMG, Batenburg JJ, Robertson B. The pulmonary surfactant system: Biochemical aspects and functional significance. Physiol Rev 1988; 68: 374-455
105. Spragg RG, Gilliard N, Richman P, Smith RM, Hite D, Pappert D. Heldt GP, Merritt TA. The adult respiratory distress syndrome: clinical aspects relevant to surfactant supplementation. In: Robertson B, Van Golde LMG. Batenburg JJ (Eds). Pulmonary surfactant. Elsevier, Amsterdam 1992. pp 685-703
106. Gommers D, Fachmann B, Surfactant therapy perspectives in adult patients. Curr Opinion Crit Care 1995; 1: 57-61
107. Hallman M, Spragg R. Harrell JH, Moser KM, Gluck L. Evidence of lung function abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids. surface activity phospholipase activity, and plasma myoinositol. J Clin Invest 1982; 70: 673-683
108. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, Hudson LD, Maunder RJ, Crim C, Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88: 1976-1981
109. Von Fricke U. Arzneimittelmarkt 1994: was war wirklich neu?-Teil 2. Deutsche Apotheker Zeitung 135. Jahrg Nr 30, 2771-2781
110. Lachmann B, Gommers D. Surfactant treatment for neonatal lung diseases other than the idiopathic respiratory distress syndrome. Lung & Respiration 1994; 11: 35-39
111. Richman PS, Spragg RG, Robertson B, Merritt TA, Curstedt T. The adult respiratory distress syndrome: first trials with surfactant replacement. Eur Respir J 1989:2[Suppl]: 109s-111s
112. Joka Th, Obertacke U. Neue medikamentöse Behandlung im ARDS: Effekt einer intrabronchialen xenogenen Surfactantapplikation. Z Herz Thorax Getäßchir 1989; 3 [Suppl]: 21-24
113. Nosaka S, Sakai T, Yonekura M, Yoshikawa K. Surfactant for adults with respiratory failure. Lancet 1990; I: 947-948
114. Stubbig K, Schmidt H, Böhrer H, Huster Th. Bach A, Motsch J. Surfactantapplikation bei akutem Lungenversagen. Anaesthesist 1992; 41: 555-558
115. Marraro G, Casiraghi G, Riva A. Effets d'un apport de surfactant chez deux adolescents leucémiques atteints de détresse respiratoire. Cahiers d'Anesthésiologie 1991; 39: 227-232
116. Haslem PL, Hughes DA, MacNaughton PD, Baker CS, Evans TW. Surfactant replacement therapy in late-stage adult respiratory' distress syndrome. Lancet 1994; 343: 1009-1011
117. Heikinheimo M, Hynynen M, Rautiainen P, Hallman M, Kukkonen S. Successful treatment of ARDS with two doses of synthetic surfactant. Chest 1994; 105: 1263-1264
118. McBrien M, Katumba JJ, Mukhtar AI, Artificial surfactant in the treatment of near drowning. Lancet 1993; 342: 1485-1486
119. Suzuki H, Ohta T, Iwata K, Yamaguchi K, Sato T. Surfactant therapy for respiratory failure due to near-drowning. Eur J Pediatr 1996; 155: 383-384
120. Knoch M, Höltermann W, Lukasewitz P. Bittersohl J. Behandlung einer Totalatelektase der linken Lunge bei schwerem ARDS mit seitengetrennter Beatmung und Surfactant-Applikation. Anästhesiol Intensivmed Notfallmed Schmerzther 1995; 30: 270-273
121. Gregory TJ, Steinberg KP, Spragg R, Hyers TM, Longmore WJ, Moxley MA, Cai G-Z, Hite RD, Smith RM, Hudson LD, Crim C, Newton P, Mitchell BR, Gold AJ. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155: 1309-1315
122. Walmrath D, Gunther A, Ghofrani HA, Schermuly R, Schneider T, Grimminger F, Seeger W. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 1996; 154: 57-62
123. Anzueto A, Baughmann RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN, Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome N Engl J Med 1996; 334: 1417-1421
124. Lachmann B, The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In: Vincent JL (Ed). Update in intensive care and emergency medicine. Springer-Verlag, Berlin, 1987, pp 123-134
125. Buheitel G, Scharf J, Harms D, Erfahrungen mit der Surfactanttherapie des adulten Atemnotsyndroms (ARDS). Monatsschr Kinderheilkd 1992; 140: 629-632
126. Putz G, Hörmann C, Koller W, Schön G. Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia. Intensive Care Med 1996; 22: 588-590
127. Slater AJ, Nichani SH, Macrae D, Wilkinson KA, Novelli V, Tasker RC. Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukemia. Intensive Care Med 1995; 21: 261-263
128. Mikawa K, Maekawa N, Nishina K, Takao Y, Yaku H, Obara H. Selective intrabronchial instillation of surfactant in a patient with pneumonia. Eur Respir J 1993; 6: 1563-1566
129. Johanson WG, Bacterial infection in adult respiratory distress syndrome. In: Zapol M, Lemaire F (Eds). Adult respiratory distress syndrome. Marcel Dekker Inc, New York. 1991, vol 50, pp 77-89
130. Scarpelli EM (Ed). The surfactant system of the lung. Lea & Febiger, Philadelphia, 1968, pp 224
131. do Campo JL, Bertranou Eg, Franco R, Zeltzer R, Pulmonary radiologie manifestations after cardiac surgery with cardiopulmonary bypass. Am Rev Respir Dis 1990; 141(Suppl): A142
132. do Campo JL, Bertranou EG, De Lorenzi A, Hager AA. Nebulised exogenous natural surfactant after cardiac surgery. Lancet 1994; 343: 482
133. Strüber M, Brandt M, Cremer J, Harringer W, Hirt SW, Haverich A. Therapy for lung failure using nitric oxide inhalation and surfactant replacement. Ann Thorac Surg 1996; 61: 1543-154
134. Houdret N, Perini JM, Galabert C, Scharfman A, Humbert P, Lamblin G, Roussel P. The high lipid content of respiratory mucins of cystic fibrosis is related to infection. Biochim Biophys Acta 1986; 880: 54-61
135. Girod S, Galabert C, Lecuire A, Zahm JM, Puchelle E. Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases. Pediatr Pulmonol 1992; 13: 22-27
136. Griese M, Birrer P, Demirsoy A. Pulmonary surfactant in cystic fibrosis. Eur Respir J 1997; 10: 1983-1988
137. Hull J, South M, Phelan P, Grimwood K. Surfactant composition in Infants and young children with cystic fibrosis. Am J Resp Crit Care Med 1997; 156: 161-165
138. King M, Brock G, Lundell C. Clearance of mucus by simulated cough. J Appl Physiol 1985; 58: 1776-1782
139. Girod de Bentzmann S, Bajolet-Laudinat O, Dupuit F, Pierrot D, Fuchey C, Plotkowski MC, Puchelle E. Protection of respiratory epithelium from Pseudomonas aeruginosa adherence by phosphatidylglycerol liposomes. Infect Immun 1994; 62: 704-708
140. Griese M, Bufler P, Teller J, Reinhardl D. Nebulization of a bovine surfactant in cystic fibrosis: a pilot study. Eur Respir J 1997; 10: 1989-1994
141. Kurashima K, Ogawa H, Ohka T, Fujimura M, Matsuda T, Kobayashi T. A pilot study of surfactant inhalation for the treatment of asthmatic attack. Jpn J Allergol 1991; 40: 160-163
142. Bambang Oetomo S, Dorrepaal C, Bos H, Gerritsen J, van der Mark TW, Koëter GH, Aalderen WMC. Surfactant nebulization does not alter airflow obstruction and bronchial responsiveness to histamine in astmatic children. Am J Respir Crit Care Med 1996; 153: 1148-1152
143. Lemarchand P, Chinet T, Collignon MA, Urzua G, Barritault L, Huchon GJ. Bronchial clearance of DTPA is increased in acute asthma but not in chronic asthma. Am Rev Respir Dis 1992; 145: 147-152
144. Kurashima K, Fujimura M, Matsuda T, Kobayashi T. Surface activity of sputum from acute asthmatic patients, Am J Respir Crit Care Med 1997; 155: 1254-1259
145. Willson DF, Jiao JH, Bauman LA, Zaritsky A, Craft H, Dockery K, Conrad D, Dalton H. Calfs lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med 1996; 24: 1316-1322
146. Perez-Benavides F, Riff E, Franks C, Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient. Pediatr Emergency Care 1995; 11: 153-155
147. Satoh D, Matsukawa S, Saishu T, Hashimoto Y, Effect of surfactant on respiratory failure associated with thoracic aneurysm surgery. Crit Care Med 1998; 26: 1660-1662